Author: Singh, D.; Joshi, K.; Samuel, A.; Patra, J.; Mahindroo, N.
Title: Alcohol-based hand sanitisers as first line of defence against SARS-CoV-2: a review of biology, chemistry and formulations Cord-id: 2qub96mz Document date: 2020_9_29
ID: 2qub96mz
Snippet: The pandemic due to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has emerged as a serious global public health issue. Since the start of the outbreak, the importance of hand-hygiene and respiratory protection to prevent the spread of the virus has been the prime focus for infection control. Health regulatory organisations have produced guidelines for the formulation of hand sanitisers to the manufacturing industries. This review summarises the studies on alcohol-based hand saniti
Document: The pandemic due to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has emerged as a serious global public health issue. Since the start of the outbreak, the importance of hand-hygiene and respiratory protection to prevent the spread of the virus has been the prime focus for infection control. Health regulatory organisations have produced guidelines for the formulation of hand sanitisers to the manufacturing industries. This review summarises the studies on alcohol-based hand sanitisers and their disinfectant activity against SARS-CoV-2 and related viruses. The literature shows that the type and concentration of alcohol, formulation and nature of product, presence of excipients, applied volume, contact time and viral contamination load are critical factors that determine the effectiveness of hand sanitisers.
Search related documents:
Co phrase search for related documents- absence presence and acute respiratory: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- absence presence and adenovirus type: 1, 2, 3
- absence presence and log reduction: 1
- absence presence and long period: 1, 2, 3, 4, 5
- absence presence and low volume: 1, 2
- acetic acid and activity comparable: 1
- acetic acid and log reduction: 1, 2
- active constituent and acute respiratory: 1, 2
- activity comparable and acute respiratory: 1, 2, 3, 4, 5, 6, 7, 8
- activity comparable and long period: 1
- acute respiratory and add benefit: 1, 2, 3
- acute respiratory and adenovirus poliovirus: 1
- acute respiratory and adenovirus type: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- acute respiratory and log reduction: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- acute respiratory and long period: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- acute respiratory and low volume: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- adenovirus poliovirus and log reduction: 1, 2
- adenovirus type and log reduction: 1, 2, 3
- log reduction and long period: 1, 2
Co phrase search for related documents, hyperlinks ordered by date